In vitro and in vivo properties of a fully human IgG1 monoclonal antibody that combats multidrug resistant Pseudomonas aeruginosa

The development of an anti-bacterial drug in the form of a monoclonal antibody (mAb) targeting an exposed virulence factor, represents an innovative therapeutic strategy. Consequently, a fully human IgG1 mAb (LST-007) targeting Pseudomonas aeruginosa (PA) flagellin type b was recombinantly expressed...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: ADAWI, AZMI, BISIGNANO, CARLO, GENOVESE, TIZIANA, FILOCAMO, ANGELA, KHOURI-ASSI, CAMELLIA, NEVILLE, ANAT, FEUERSTEIN, GIORA Z., CUZZOCREA, SALVATORE, NEVILLE, LEWIS F.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: D.A. Spandidos 2012
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3573743/
https://ncbi.nlm.nih.gov/pubmed/22735858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2012.1040
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg